Loading clinical trials...
Loading clinical trials...
The goal of this observational study is to learn about infectious complications in patients affected by B-cell acute lymphoblastic leukemia treated with inotuzumab-ozogamicin (INO). The main question ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
NCT07655050 · Kidney Calculi, Urolithiasis, and more
NCT07400029 · Acute Lymphoblastic Leukemia
NCT07666464 · Therapy, Pleural Infections
NCT07328503 · Acute Lymphoblastic Leukemia, B-All
NCT06853314 · HIV Infections, Alcohol Use Disorder, and more
UOC Ematologia Fondazione Policlinico Universitario A.Gemelli
Roma
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions